The Journal for ImmunoTherapy of Cancer (JITC) is an open access, peer-reviewed journal that aims to enrich communication and advance scientific understanding in the rapidly evolving fields of tumor immunology and cancer immunotherapy. Topics of interest range across the basic science-translational-clinical spectrum and include tumor-host interactions, the tumor microenvironment, animal models, predictive and prognostic immune biomarkers, novel pharmaceutical and cellular therapies, vaccines, combination immune-based therapies, and immune-related toxicity.
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Articles published
Times cited
2019
2020
2021
2022
2023
2024
2025
2026
Source: OpenAlex · Note: citations accumulate over time so older years appear higher
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Cancer ResearchQ1
ImmunologyQ1
Immunology and AllergyQ1
Molecular MedicineQ1
OncologyQ1
PharmacologyQ1
Subject Classification
Web of Science Categories
ImmunologyOncology
Scopus Categories
Molecular MedicinePharmacologyImmunologyCancer ResearchImmunology and AllergyOncology
Research Topics (OpenAlex)
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesCAR-T cell therapy researchImmune Cell Function and InteractionImmune cells in cancerMonoclonal and Polyclonal Antibodies ResearchVirus-based gene therapy researchFerroptosis and cancer prognosisCancer Research and TreatmentsT-cell and B-cell Immunology